PUBLIC CONTRACT · 2024
Aquisição de medicamentos do aparelho cardiovascular (AQ2023305)
- Contract value
- €779.35
- Signed on
- 20 November 2024
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11055297PUBLISHED SUBJECT
Aquisição de IRBESARTAN 300 MG COMP, ISOPRENALINA 1 MG/5 ML SOL INJ FR 5 ML IV, NIFEDIPINA 60 MG COMP LP e PERINDOPRIL 5 MG COMP
Parties involved
- Place of performance
- Portugal, Lisboa, Lisboa
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Generis Farmacêutica, S.A. · Tax ID 508107997
- Bidder
- Bluepharma Genéricos - Comércio de Medicamentos S.A. · Tax ID 506037169
- Bidder
- KRKA FARMACEUTICA · Tax ID 507981227
- Bidder
- BIOJAM SA Health Consulting · Tax ID 513642749
Values and timeline
- Contract price
- €779.35
- Procedure base price
- €15,918.90
- Total effective price
- Not reported on Portal BASE
- Publication date
- 29 November 2024
- Award date
- 11 November 2024
- Signing date
- 20 November 2024
- Performance period
- 40 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- 305/2023 - Medicamentos do aparelho cardiovascular
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7263011
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.